Upton GA, Tinley P, Al-Aubaidy H, Crawford R
The distinctions between the molecular mechanisms of mucin production and secretion within muco-obstructive lung diseases are discussed with a focus on several cytokines such as IL-1, secretagogues like ATP, and protein chaperones such as ERN2
This chronic low-grade inflammation drives insulin resistance, dyslipidemia, and cardiovascular risk
doi: 10.3803/EnM.2016.31.2.258
Clinical Disorders and Physiological Pathways Impacted by GLP-1 GLP-1 has emerged as a prominent therapeutic target for type 2 diabetes mellitus (T2DM) and obesity and has recently been shown to have potential therapeutic effects on comorbidities in these populations, such as autoimmune processes, chronic kidney disease (CKD), cardiovascular disease, and Alzheimers disease [10]
Asking further questions to your health provider and gaining more knowledge on the treatment is a great first step in getting prescribed Semaglutide GLP-1 and it is encouraged to do so
